This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HCAQ vs. MGX, VTGN, ORMP, SRTS, VANI, XBIT, VXRT, NVNO, CO, and CORBFShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Metagenomi (MGX), VistaGen Therapeutics (VTGN), Oramed Pharmaceuticals (ORMP), Sensus Healthcare (SRTS), Vivani Medical (VANI), XBiotech (XBIT), Vaxart (VXRT), enVVeno Medical (NVNO), Global Cord Blood (CO), and Global Cord Blood (CORBF). These companies are all part of the "medical" sector. HealthCor Catalio Acquisition vs. Its Competitors Metagenomi VistaGen Therapeutics Oramed Pharmaceuticals Sensus Healthcare Vivani Medical XBiotech Vaxart enVVeno Medical Global Cord Blood Global Cord Blood HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Metagenomi (NASDAQ:MGX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment. Which has preferable earnings & valuation, HCAQ or MGX? HealthCor Catalio Acquisition has higher earnings, but lower revenue than Metagenomi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthCor Catalio AcquisitionN/AN/AN/AN/AN/AMetagenomi$52.29M1.61-$78.06M-$2.11-1.07 Do institutionals and insiders hold more shares of HCAQ or MGX? 84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. 17.8% of Metagenomi shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor HCAQ or MGX? In the previous week, Metagenomi had 1 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 1 mentions for Metagenomi and 0 mentions for HealthCor Catalio Acquisition. HealthCor Catalio Acquisition's average media sentiment score of 0.00 equaled Metagenomi'saverage media sentiment score. Company Overall Sentiment HealthCor Catalio Acquisition Neutral Metagenomi Neutral Is HCAQ or MGX more profitable? HealthCor Catalio Acquisition has a net margin of 0.00% compared to Metagenomi's net margin of -172.21%. HealthCor Catalio Acquisition's return on equity of 0.00% beat Metagenomi's return on equity.Company Net Margins Return on Equity Return on Assets HealthCor Catalio AcquisitionN/A N/A N/A Metagenomi -172.21%-31.21%-22.21% Do analysts prefer HCAQ or MGX? Metagenomi has a consensus target price of $13.00, suggesting a potential upside of 477.78%. Given Metagenomi's stronger consensus rating and higher probable upside, analysts clearly believe Metagenomi is more favorable than HealthCor Catalio Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthCor Catalio Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Metagenomi 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryMetagenomi beats HealthCor Catalio Acquisition on 6 of the 10 factors compared between the two stocks. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.95M$11.41B$5.48B$9.53BDividend YieldN/A1.84%4.73%4.09%P/E RatioN/A18.3328.8623.83Price / SalesN/A7.60371.4466.13Price / CashN/A11.9035.4557.96Price / BookN/A2.028.265.54Net IncomeN/A$344.53M$3.25B$259.28M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$1.03-2.8%N/A-9.4%$21.95MN/A0.002Gap DownHigh Trading VolumeMGXMetagenomi2.44 of 5 stars$2.39+1.7%$13.00+443.9%-35.7%$89.34M$52.29M-1.13236VTGNVistaGen Therapeutics1.0279 of 5 stars$3.06flatN/A-13.2%$89.23M$490K-1.8440News CoverageORMPOramed Pharmaceuticals0.5957 of 5 stars$2.18-1.1%N/A-10.5%$88.85M$1.34M-4.9410News CoveragePositive NewsAnalyst RevisionSRTSSensus Healthcare1.9185 of 5 stars$5.34+0.2%$11.67+118.5%-10.7%$87.79M$41.81M53.4040News CoverageUpcoming EarningsGap DownVANIVivani Medical2.6628 of 5 stars$1.48-1.3%$4.00+170.3%+9.9%$87.68MN/A-3.4420News CoveragePositive NewsShort Interest ↑XBITXBiotech0.9764 of 5 stars$2.87+0.5%N/A-61.0%$87.63M$4.01M-2.23100News CoveragePositive NewsShort Interest ↑VXRTVaxart3.3247 of 5 stars$0.38-5.3%$3.00+693.9%-46.0%$86.51M$47.40M-1.40120News CoveragePositive NewsNVNOenVVeno Medical0.3617 of 5 stars$4.93+0.7%N/A-8.6%$86.38MN/A-4.1730News CoverageEarnings ReportGap UpCOGlobal Cord BloodN/A$0.71flatN/A-52.7%$86.30M$1.24B1.111,202CORBFGlobal Cord BloodN/A$0.71+29.1%N/AN/A$86.30M$196.12M0.001,200 Related Companies and Tools Related Companies MGX Competitors VTGN Competitors ORMP Competitors SRTS Competitors VANI Competitors XBIT Competitors VXRT Competitors NVNO Competitors CO Competitors CORBF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCAQ) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCAQ Stock Alerts